Advertisement

Topics

NICE turns down Novartis' Aimovig, flagging clinical trial concerns

04:37 EST 11 Jan 2019 | BioPharmaDive

The most clinically important patients were excluded from studies, the reviewing committee concluded in its draft decision to not recommend U.K. coverage of the migraine drug.

Original Article: NICE turns down Novartis' Aimovig, flagging clinical trial concerns

NEXT ARTICLE

More From BioPortfolio on "NICE turns down Novartis' Aimovig, flagging clinical trial concerns"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...